07:54 AM EDT, 03/19/2026 (MT Newswires) -- Glaukos ( GKOS ) said Thursday it launched Epioxa for the treatment of keratoconus, a rare eye disease.
The drug is commercially available through direct ordering and the company's specialty pharmaceutical distribution network, Glaukos ( GKOS ) said.
Glaukos ( GKOS ) shares were down 0.9% in Thursday premarket trading.